DP 4088
Alternative Names: DP-4088; DPOC-4088Latest Information Update: 28 Apr 2018
At a glance
- Originator Merck & Co
- Developer Diakron Pharmaceuticals; Orchid Chemicals & Pharmaceuticals
- Class Antithrombotics; Small molecules
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Blood coagulation disorders
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for phase-I development in Coagulation-disorders in Belgium (PO, Tablet)
- 28 Apr 2018 No recent reports of development identified for phase-I development in Coagulation-disorders in USA (PO, Tablet)
- 13 Apr 2016 This programme is still active